Preventing premature non-communicable disease mortality necessitates a thorough review
of one of the most important risk factors for stroke, which is atrial fibrillation (AF). The latter …

Aims To compare the prevalence of electrocardiogram (ECG)-documented atrial fibrillation
(or flutter)(AF) across eight regions of the world, and to examine antithrombotic use and …

Background Our previous review reported great variability in the incidence and prevalence
of atrial fibrillation (AF) in non-Western cohorts, especially from Asian countries; in recent …

Background Although atrial fibrillation (AF) is accepted as the most common sustained
cardiac arrhythmia, most published epidemiologic studies focus on predominantly white …

With increasing life-expectancy and changing demographics, non-valvular atrial fibrillation
(AF) is currently the most common indication for long-term oral anticoagulation (OAC) in low …

Background Differences exist in oral anticoagulation (OAC) use between different
populations with atrial fibrillation (AF), which may be associated with varying outcomes …

Introduction Although guideline-adherent antithrombotic therapy (ATT) for stroke prevention
in atrial fibrillation (AF) is associated with lower mortality and thromboembolism, ATT uptake …

Health care in Sub-Saharan Africa is being challenged by a double burden of disease as
lifestyle diseases common in the developed world, such as stroke and atrial fibrillation (AF) …

Atrial fibrillation (AF) is a major risk factor for stroke, especially in the elderly. Increased life
expectancies mean that AF-related stroke is a growing global public health concern …

Background. Prevention of stroke and systemic embolism (SE) prevention in patients with
atrial fibrillation (AF) has radically changed in recent years. Data on contemporary utilization …